Clinical investigation of new medicinal products for the treatment of acute coronary syndrome - Scientific guideline

HumanScientific guidelines

This guideline replaces 'Points to consider on the clinical investigation of new medicinal products for the treatment of acute coronary syndrome (ACS) without persistent ST segment elevation' (CPMP/EWP/570/98) and 'Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction (STEMI)' (CPMP/EWP/967/01).

Keywords: Acute coronary syndrome, STE-ACS, NSTE-ACS

Current effective version

Document history - First version

Document history - Superseded document

Share this page